Role of biomarkers in identifying and understanding environmentally induced disease

Ellen Silbergeld, Devra Lee Davis

Research output: Contribution to journalArticle

Abstract

Establishing associations between environmental agents and disease presents challenges to both epidemiologists and toxicologists, particularly in cases of complex gene-environment interactions and when there is a long latency between exposure and disease. Biologic markers, physiological signals that reflect exposure, early cellular response, or inherent or acquired susceptibilities, provide a new strategy for resolving some of these problems. Biomarker research assumes that toxicant-induced diseases are progressive and that injury proceeds from entry of the toxicant into target cells, which induces subcellular biochemical events, to cell- and organ-level events that eventually induce irreversible or persistent organism dysfunction. The epidemiologic value of a biomarker lies in its ability to predict backward toward exposure and forward toward risk of clinical outcome, which is largely unknown. Research in mechanistic toxicology will advance the range of useful biomarkers in epidemiology and clinical medicine.

Original languageEnglish (US)
Pages (from-to)1363-1367
Number of pages5
JournalClinical Chemistry
Volume40
Issue number7 II
StatePublished - 1994
Externally publishedYes

Fingerprint

Biomarkers
Epidemiology
Gene-Environment Interaction
Medicine
Clinical Medicine
Genes
Research
Toxicology
Wounds and Injuries

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Role of biomarkers in identifying and understanding environmentally induced disease. / Silbergeld, Ellen; Davis, Devra Lee.

In: Clinical Chemistry, Vol. 40, No. 7 II, 1994, p. 1363-1367.

Research output: Contribution to journalArticle

@article{8a1ec7c504bd46a0931beed40c520d1d,
title = "Role of biomarkers in identifying and understanding environmentally induced disease",
abstract = "Establishing associations between environmental agents and disease presents challenges to both epidemiologists and toxicologists, particularly in cases of complex gene-environment interactions and when there is a long latency between exposure and disease. Biologic markers, physiological signals that reflect exposure, early cellular response, or inherent or acquired susceptibilities, provide a new strategy for resolving some of these problems. Biomarker research assumes that toxicant-induced diseases are progressive and that injury proceeds from entry of the toxicant into target cells, which induces subcellular biochemical events, to cell- and organ-level events that eventually induce irreversible or persistent organism dysfunction. The epidemiologic value of a biomarker lies in its ability to predict backward toward exposure and forward toward risk of clinical outcome, which is largely unknown. Research in mechanistic toxicology will advance the range of useful biomarkers in epidemiology and clinical medicine.",
author = "Ellen Silbergeld and Davis, {Devra Lee}",
year = "1994",
language = "English (US)",
volume = "40",
pages = "1363--1367",
journal = "Clinical Chemistry",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry Inc.",
number = "7 II",

}

TY - JOUR

T1 - Role of biomarkers in identifying and understanding environmentally induced disease

AU - Silbergeld, Ellen

AU - Davis, Devra Lee

PY - 1994

Y1 - 1994

N2 - Establishing associations between environmental agents and disease presents challenges to both epidemiologists and toxicologists, particularly in cases of complex gene-environment interactions and when there is a long latency between exposure and disease. Biologic markers, physiological signals that reflect exposure, early cellular response, or inherent or acquired susceptibilities, provide a new strategy for resolving some of these problems. Biomarker research assumes that toxicant-induced diseases are progressive and that injury proceeds from entry of the toxicant into target cells, which induces subcellular biochemical events, to cell- and organ-level events that eventually induce irreversible or persistent organism dysfunction. The epidemiologic value of a biomarker lies in its ability to predict backward toward exposure and forward toward risk of clinical outcome, which is largely unknown. Research in mechanistic toxicology will advance the range of useful biomarkers in epidemiology and clinical medicine.

AB - Establishing associations between environmental agents and disease presents challenges to both epidemiologists and toxicologists, particularly in cases of complex gene-environment interactions and when there is a long latency between exposure and disease. Biologic markers, physiological signals that reflect exposure, early cellular response, or inherent or acquired susceptibilities, provide a new strategy for resolving some of these problems. Biomarker research assumes that toxicant-induced diseases are progressive and that injury proceeds from entry of the toxicant into target cells, which induces subcellular biochemical events, to cell- and organ-level events that eventually induce irreversible or persistent organism dysfunction. The epidemiologic value of a biomarker lies in its ability to predict backward toward exposure and forward toward risk of clinical outcome, which is largely unknown. Research in mechanistic toxicology will advance the range of useful biomarkers in epidemiology and clinical medicine.

UR - http://www.scopus.com/inward/record.url?scp=0028226135&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028226135&partnerID=8YFLogxK

M3 - Article

C2 - 8013120

AN - SCOPUS:0028226135

VL - 40

SP - 1363

EP - 1367

JO - Clinical Chemistry

JF - Clinical Chemistry

SN - 0009-9147

IS - 7 II

ER -